 | Sage Therapeutics, Inc. | |||
| NGM : SAGE || Location: United States | ||||
$14.0+1.05 (+8.11%) |
2.31 M | 13.45 - 14.52 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 8.603 M |
| March 15, 2024 | 8.400 M |
| Feb. 29, 2024 | 7.907 M |
| Feb. 15, 2024 | 9.022 M |
| Jan. 31, 2024 | 7.856 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.30 | -1.80 | -38.15% |
| 09/30/2023 | -2.79 | -3.37 | -21.00% |
| 06/30/2023 | -2.60 | -2.68 | -2.89% |
| 03/31/2023 | -2.55 | -2.46 | 3.37% |
| 12/31/2022 | -2.44 | -2.47 | -1.42% |
SAGE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 60.107M | Shares Float | 47.550M |
| Short Float | 8.603M | Market Cap | 778.39M |
| Institution ownership | 95.59% | Insider ownership | 12.557% |
| Earnings Date | 04/25/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -9.05 | Forward EPS | -4.84 |